Upstate Active Clinical Trials

Study Title:

A Phase II Study of Abemaciclib in Combination with Letrozole in Advanced, Recurrent or Metastatic Endometrioid Endometrial Cancer

What is the purpose of the study? (in Layman's terms, please describe the study)

To determine the objective response rate of patients with advanced, persistent, or recurrent endometrioid endometrial cancer.

Upstate Institutional Review Board (IRB) Number:

1663346

Study/Protocol ID:

GOG 3039

Study Phase:

II

Patient Age Group:

Adults

Principal Investigator:

Mary J Cunningham, MD

What is involved if I participate?

• How long is the study?
  5 years
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  No
• What tests and procedures are involved?
  CT Scan CAP w/contrast, EKG, H&P, Vitals (incl. pulse ox), ECOG, AE report, CBC w/ diff, CMP, Urinalysis, misc. lab test for pre-treatment specimens, archive tissue, path report submitted in RAVE, MMR, MSI, ER/PR status if available

Where will the study take place?

Madison Irving, Cancer center

Other Information:

A Phase II Study of Abemaciclib in Combination with Letrozole in Advanced,
Recurrent or Metastatic Endometrioid Endometrial Cancer

ClinicalTrials.Gov ID:

NCT04393285

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Sonia Masood
Phone: 315-464-8232
Email: [email protected]

Return to Previous Page || Search Again